Tecan Group AG (TECN.VI)
Vienna · EUR · Healthcare · Medical Instruments & Supplies
€261.60 (-1.36%) as of
Key statistics
- Market cap
- 3.22B
- EPS (TTM)
- -9.89
- Dividend yield
- 1.23%
- 52-week range
- 122.00 – 272.80
- Beta
- 1.01
- Revenue (TTM)
- 870.53M
- Profit margin
- -13.36%
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Männedorf, Switzerland
- Employees
- 3,000
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.